TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
115.90
+0.72 (0.63%)
Oct 8, 2025, 11:29 AM EDT - Market open
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $3.95 billion as of October 8, 2025. Its market cap has decreased by -28.22% in one year.
Market Cap
3.95B
Enterprise Value
4.02B
1-Year Change
-28.22%
Ranking
Category
Stock Price
$115.90
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $3.95B, an increase of 773.21%. That is a compound annual growth rate of 40.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 3.93B | 87.64% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | 540.50M | 34.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |